Joy Malignant

Petros Anastasiadis · 2026 · $8.99 · Adventure · deal grade B

Measured on 2026-09-24 03:42 UTC, 12 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $1.8k to $2.7k per month
• Opportunity: $2.9k per month at x1.30 dormancy
• Estimated lifetime owners: 2.7k
• 100% positive across 75 reviews · 29.5 reviews/month

Why it's flagged

• Developer active, last post 2 months ago
• Store page localized in only 1 language(s)
• Last discounted 1 months ago, 1 sales in the last 12 months

Analyst notes (AI-assisted)

Note written 2026-08-30; the live figures above take precedence over any numbers in it.

A solo-dev short-form narrative CRPG about identity and transformation, influenced by Citizen Sleeper and Disco Elysium, with a reactive 'mosaic' character system.

Joy Malignant has found a tight niche audience (100% positive, strong repeat plays) but remains nearly invisible outside indie circles, earning modest residuals per the live figures. The title punches above its weight in writing quality and mechanical invention for a one-person studio output. This is a proof-of-concept for a developer who, with modest backing or partnership, could anchor a larger project; the game itself is less acquisition target and more calling card for a revival or publishing partnership that expands the creator's reach. Most realistic play: publishing.

• Risk: Narrow audience: narrative-heavy, short (2-3 hours), and mechanically derivative of successful indie darlings; growth ceiling may be low without major marketing spend or bundle placement.
• Risk: Solo-dev sustainability: single founder, one released title, limited industry track record; team expansion or retention during growth phase is unvalidated.

This case as Markdown · Estimates carry ±30-50% error per title.